Upon delivery, miR-598 targeted and inhibited the expression of THBS2, which inhibited the proliferation, migration, and invasion of NSCLC cells in vitro, while arresting tumor growth and metastasis in vivo. The gene discussed is THBS2; the disease is neoplasm.